GB829245A - Resin-drug compounds - Google Patents

Resin-drug compounds

Info

Publication number
GB829245A
GB829245A GB31985/57A GB3198557A GB829245A GB 829245 A GB829245 A GB 829245A GB 31985/57 A GB31985/57 A GB 31985/57A GB 3198557 A GB3198557 A GB 3198557A GB 829245 A GB829245 A GB 829245A
Authority
GB
United Kingdom
Prior art keywords
drug
phenylethylamine
exchange resin
derivative
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31985/57A
Inventor
Wilfred Herbert Linnell
Stephen Paul Rety
Herbert Timmington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clinical Products Ltd
Original Assignee
Clinical Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Products Ltd filed Critical Clinical Products Ltd
Priority to GB31985/57A priority Critical patent/GB829245A/en
Publication of GB829245A publication Critical patent/GB829245A/en
Application status is Expired legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/44Preparation of metal salts or ammonium salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Abstract

Resinate salts of b -phenylethylamines are made by combining a derivative of b -phenylethylamine with an acidic cationic ion-exchange resin, for example, either a styrene polymer cross-linked with divinyl benzene and containing sulphonic acid groups, or a cross-linked polymerized methacrylic acid. The b -phenylethylamine derivative may be a drug such as ephedrine, adrenaline, isoprenaline, amphetamine or methylamphetamine and may be reacted with the ion-exchange resin in solution as the free base or as the hydrochloride. The resinate salts of drugs may be used in pharmacy since the drug is slowly released in the body.
GB31985/57A 1957-10-14 1957-10-14 Resin-drug compounds Expired GB829245A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB31985/57A GB829245A (en) 1957-10-14 1957-10-14 Resin-drug compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB31985/57A GB829245A (en) 1957-10-14 1957-10-14 Resin-drug compounds
CH6444058A CH379057A (en) 1957-10-14 1958-09-26 A method for manufacturing a resin-drug compound

Publications (1)

Publication Number Publication Date
GB829245A true GB829245A (en) 1960-03-02

Family

ID=10331315

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31985/57A Expired GB829245A (en) 1957-10-14 1957-10-14 Resin-drug compounds

Country Status (2)

Country Link
CH (1) CH379057A (en)
GB (1) GB829245A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1182390B (en) * 1960-12-27 1964-11-26 Dr Gustavo Damilano A method for reducing the rate of absorption of therapeutically active substances soluble
EP0435684A1 (en) * 1989-12-28 1991-07-03 R.P. Scherer Corporation Freeze-dried dosage forms and methods for preparing the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1182390B (en) * 1960-12-27 1964-11-26 Dr Gustavo Damilano A method for reducing the rate of absorption of therapeutically active substances soluble
EP0435684A1 (en) * 1989-12-28 1991-07-03 R.P. Scherer Corporation Freeze-dried dosage forms and methods for preparing the same
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same

Also Published As

Publication number Publication date
CH379057A (en) 1964-06-30

Similar Documents

Publication Publication Date Title
DK111391B (en) A process for the preparation of soft flexible contact lenses of the swollen hydrogels.
ES311517A1 (en) A process for the manufacture consisting essentially of a polycarbonate resin with high resistance to degradation by ultraviolet light article.
DK108199C (en) A curable ethylene copolymer for use as adhesive and coating materials.
ES294367A1 (en) Procedure, with its director apparatus for manufacturing articles of solidified resin, fiber reinforced
DK124942B (en) A process for the preparation of alkanolaminderivater or acid addition salts thereof.
DK105436C (en) A process for the production of contact lenses.
DK106646C (en) A curable ethylene copolymer for use as adhesive and coating materials.
ES267532A1 (en) A process for making a pharmaceutical preparation
DK114427B (en) Above method for the preparation of salts of carboxyl group-containing, swellable, substantially water-insoluble resins for use as anti-diarrhea agents.
AT258471B (en) A process for the preparation of drug formulations for percutaneous administration,
IT1146975B (en) of insulin delivery system on the basis of organic request
NL161176C (en) A process for the preparation of a curable epoxy resin composition, as well as with application of such molded article.
ES488986A0 (en) A device for infusion implastable to administer drug doses accurately regulated exte-rior under control.
DK107516C (en) A machine for the continuous manufacture of corrugated sheets of thermoplastic plastic.
ES397418A1 (en) A process for the preparation of a retroreflective construction containing spherical lens elements.
DE1467966A1 (en) A process for preparing a pharmaceutical composition with Freigabeverzoegerung for the asthma therapy
ES8600215A1 (en) A process for preparing an antigenic oligopeptides
ES388698A1 (en) Process for the preparation of small pellets medi-camentosas for oral administration with a re-tardador of the active substance release coating.
DE2332177A1 (en) Curing agent for aqueous epoxy resin dispersions
DK123104B (en) A process for the preparation of 7- (α-amino-α-phenylacetamido) -3-methyl-3-cephem-4-carboxylic acid compounds or salts thereof.
SE7902166L (en) Process for the production tell up from a polymer composition
BR7300160D0 (en) Process for the production of a resin material and the resinous material
ES273274A1 (en) Process for the preparation of novel compositions containing dextromethorphan or an acid addition salt thereof
ES261175A1 (en) Process for the preparation of a pharmaceutical vector
BR7208714D0 (en) A process for preparing a low molecular weight polymer of an ethylenically unsaturated monomer